These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14468177)

  • 1. [Studies on the antitubercular action of N-acetyl-D-glucosaminyl-isonicotinic acid hydrazide (AG-INH)].
    MAEKAWA N; HAMADA K; KAWAI M; NAKAI J; KUSUNODA F; MORI K
    Kyoto Daigaku Kekkaku Kenkyusho Kiyo; 1961 Mar; 9():142-7. PubMed ID: 14468177
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antitubercular activity of the calcium methansulfonate of isonicotinic acid hydrazide].
    FARIAS CE; DI CARLO FC; CAFIRE N; FERNANDEZ H
    Dia Med; 1963 Jun; 35():837-8. PubMed ID: 13944367
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the therapeutic action of ketonic isonicotinic acid hydrazides in experimental tuberculosis in guinea pigs (isonicotinic acid hydrazide oxalacetate, isonicotinic acid hydrazide mercaptopyruvate, isonicotinic acid hydrazide brompyruvate, isonicotinoyl alpha-ketoglutaric acid, levulinic isonicotinic acid hydrazide)].
    OERIU S; RADULESCU D; VASILESCU C; ZIRRA AM; CHIRESCU N; WINTER D
    Bul Stiint Sect Stiint Medicale Acad Republicii Pop Romane; 1956; 8(3):859-66. PubMed ID: 13413322
    [No Abstract]   [Full Text] [Related]  

  • 4. [The influence of the simultaneous administration of 5-bromosalicylohydroxamic acid (T-40) and isonicotinic acid hydrazide on the concentration of free isonicotinic acid hydrazide in the urine of patients with pulmonary tuberculosis].
    Zduńczyk-Pawelek H; Otrzonsek N; Kostrzewska K
    Gruzlica; 1965 May; 33(5):411-5. PubMed ID: 5319220
    [No Abstract]   [Full Text] [Related]  

  • 5. [Isonicotinic acid hydrazide as an antituberculosis drug].
    CATTANEO C
    Lotta Tuberc; 1952; 22(1-2):5-8. PubMed ID: 14940011
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro and in vivo activities of acylated derivatives of isoniazid against mycobacterium tuberculosis.
    Hearn MJ; Cynamon MH
    Drug Des Discov; 2003; 18(4):103-8. PubMed ID: 15553921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Further clinical studies on the effect of isonicotinic acid hydrazide paraaminosalicylate (dipashin) on the course of pulmonary tuberculosis with regard to bacillary sensitivity to isonicotinic acid hydrazide].
    JANCZY S
    Gruzlica (1926); 1959 Sep; 27():915-20. PubMed ID: 14406649
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and antimycobacterial activity of isoniazid derivatives from renewable fatty acids.
    Rodrigues MO; Cantos JB; D'Oca CR; Soares KL; Coelho TS; Piovesan LA; Russowsky D; da Silva PA; D'Oca MG
    Bioorg Med Chem; 2013 Nov; 21(22):6910-4. PubMed ID: 24103427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of antituberculars: preparation and evaluation against Mycobacterium tuberculosis of an isoniazid Schiff base.
    Hearn MJ; Cynamon MH
    J Antimicrob Chemother; 2004 Feb; 53(2):185-91. PubMed ID: 14688045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of crotonylidene isonicotinic acid hydrazone (CIH) and mesityl oxide hydrazone (MIH) in experimental tuberculosis.
    GUPTA SK; MATHUR IS; MUKERJI B
    Arch Int Pharmacodyn Ther; 1962 Jan; 135():178-86. PubMed ID: 13903004
    [No Abstract]   [Full Text] [Related]  

  • 11. [The experimental antitubercular activity of isonicotinic acid hydrazide].
    RIST N; GRUMBACH F
    C R Seances Soc Biol Fil; 1952 Apr; 146(7-8):564-6. PubMed ID: 12998159
    [No Abstract]   [Full Text] [Related]  

  • 12. Binding of toxic metabolites of isoniazid by aconiazide.
    Held HR; Landi S
    J Pharm Sci; 1980 Nov; 69(11):1284-7. PubMed ID: 7452457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoniazid derivatives and their anti-tubercular activity.
    Hu YQ; Zhang S; Zhao F; Gao C; Feng LS; Lv ZS; Xu Z; Wu X
    Eur J Med Chem; 2017 Jun; 133():255-267. PubMed ID: 28390957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observations and experiences with isonicotinic acid hydrazide (INH).
    STEWART JF
    J Ky State Med Assoc; 1953 Jun; 51(6):229-38. PubMed ID: 13069854
    [No Abstract]   [Full Text] [Related]  

  • 15. [SUPPLEMENTARY CLINICAL STUDY OF ALPHA-PROPYL-ISONICOTINIC ACID THIOAMIDE (1321 TH)].
    BROUET G; CHEVALLIER J; MEEUS BITH L; NEVOT P
    Rev Tuberc Pneumol (Paris); 1965; 29():133-58. PubMed ID: 14326306
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chemotherapy of Stefansky leprosy with N-acetyl-D-glucosaminyl-isoniazid & [beta-methyl-mercaptopropionaldehyde]isonicotinic acid hydrazone].
    KIMMIG J; MEYER-ROHN J
    Hautarzt; 1957 Jul; 8(7):320-2. PubMed ID: 13512863
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution to the knowledge of the clinical antitubercular activity of sulfoniazid].
    RAVAZZONI C; SADOWSKI LF; SCARPONI F
    Lotta Tuberc; 1959; 29():943-54. PubMed ID: 14436538
    [No Abstract]   [Full Text] [Related]  

  • 18. [INH THERAPY IN INH RESISTANCE].
    SERI I
    Tuberk Tudobetegsegek; 1964 Apr; 17():98-103. PubMed ID: 14186516
    [No Abstract]   [Full Text] [Related]  

  • 19. Metal chelates and antitubercular activity. IV. Isonicotinyl hydrazide.
    FOYE WO; DUVALL RN
    J Am Pharm Assoc Am Pharm Assoc; 1958 Apr; 47(4):285-8. PubMed ID: 13538807
    [No Abstract]   [Full Text] [Related]  

  • 20. The influence of NAT2 genotypes on the plasma concentration of isoniazid and acetylisoniazid in Chinese pulmonary tuberculosis patients.
    Chen B; Li JH; Xu YM; Wang J; Cao XM
    Clin Chim Acta; 2006 Mar; 365(1-2):104-8. PubMed ID: 16182272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.